AMENDMENT TO STOCK SUBSCRIPTION AGREEMENT
 
This AMENDMENT TO STOCK SUBSCRIPTION AGREEMENT (this “Amendment”) is made and
entered into as of April 30, 2010 by and among (a) China Medicine Corporation, a
Nevada corporation (the “Company”), (b) Mr. Yang Senshan, (the “Executive
Shareholder”) and (c) OEP CHME Holdings, LLC, a Delaware limited liability
company (the “Investor”).
 
WITNESSETH
 
WHEREAS, the Company, the Executive Shareholder and the Investor entered into a
Stock Subscription Agreement dated December 31, 2009 (the “Stock Subscription
Agreement”); and
 
WHEREAS, the Company, the Executive Shareholder and the Investor intend to
delete and replace the definition of “C” in Section 4.9(a) and the definition
“F” in Section 4.9(b) of the Stock Subscription Agreement with the definitions
below in order to clarify the intention of the parties in connection with the
calculation of “2010 Additional Shares” and “2011 Additional Shares”.
 
NOW, THEREFORE, in consideration of the foregoing, the parties hereto agree as
follows:
 
Section 1.  The definition of “C” in Section 4.9(a) of the Stock Subscription
Agreement shall be deleted and replaced with the following:

“C = Total number of Common Shares held by Investor and total number of Common
Shares underlying Redeemable Convertible Preferred Shares held by Investor at
the time of determination but prior to the issuance of any 2010 Additional
Shares”

Section 2.  The definition of “F” in Section 4.9(b) of the Stock Subscription
Agreement shall be deleted and replaced with the following:

“F = Total number of Common Shares held by Investor and total number of Common
Shares underlying Redeemable Convertible Preferred Shares held by Investor at
the time of determination but prior to the issuance of any 2011 Additional
Shares”

Section 3.  Capitalized terms not otherwise defined in this Amendment shall have
the same meanings given to them in the Stock Subscription Agreement.

Section 4.  This Amendment shall be deemed to be an integral part of the Stock
Subscription Agreement and shall be deemed to have taken effect retrospectively
since December 31, 2009 for the purpose of interpreting Section 4.9(a) and
Section 4.9(b) of the Stock Subscription Agreement.

[Signature Pages Follow]

 
 

--------------------------------------------------------------------------------

 

IN WITNESS WHEREOF, the undersigned has caused this Amendment to be duly
executed by its authorized signatory as of the date first indicated above.
 
CHINA MEDICINE CORPORATION
   
By:
   /s/ Yang Senshan
 
Name: Yang Senshan
 
Title: Chief Executive Officer

 
 
 

--------------------------------------------------------------------------------

 

IN WITNESS WHEREOF, the undersigned has caused this Amendment to be duly
executed by their respective authorized signatories as of the date first
indicated above.
 
OEP CHME HOLDINGS, LLC

By: One Equity Partners III, L.P.,
its Manager

By: OEP General Partner III, L.P.,
its General Partner

By: OEP Holding Corporation,
its General Partner

By:
 /s/    Bradley J Coppens
Name:  Bradley J Coppens
Title:    Vice President

 
 
 

--------------------------------------------------------------------------------

 

IN WITNESS WHEREOF, the undersigned has duly executed this Amendment as of the
date first indicated above.
 
Mr. Yang Senshan
 
     /s/ Yang Senshan

 
 
 

--------------------------------------------------------------------------------